Session III. Targeted therapies: biological rationale and clinical implications
Tracks
Auditorium
Friday, October 7, 2022 |
9:00 - 10:15 |
Auditorium |
Speaker/s
MD-PhD Jennifer Brown
Physician
Dana-Farber Cancer Institute, Harvard Medical School
From bench to bedside: Targeting signaling pathways
9:00 - 9:20Biography
Prof. John Seymour
Other
Department Of Haematology
From bench to bedside: Targeting apoptosis
9:20 - 9:40Biography
MD-PhD Peter Hillmen
Physician
University Of Leeds
Combined inhibition of signaling and anti-apoptotic pathways
9:40 - 10:00Biography
Chairs/Moderators
Matthew S. Davids
Physician
Dana-Farber Cancer Institute, USA
Carol Moreno
Hospital Santa Creu I Sant Pau Barcelona, Spain